AbbVie (NYSE:ABBV) Exceeds Q3 Expectations; Hikes Dividend - TipRanks.com

Pharmaceutical behemoth AbbVie (NYSE:ABBV) delivered a better-than-anticipated third-quarter performance, with EPS of $2.95 outpacing expectations by $0.08. Revenue of $13.93 billion also fared better than the consensus by $220 million, despite a year-over-year decline of 5.9%. During the quarter,…#eps #immunology #humira #skyrizi #rinvoq #abbviesoncology #imbruvica #vraylar #ubrelvy #botox
Source: Reuters: Health - Category: Consumer Health News Source Type: news